XXII 22nd Century Group Inc.: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

22nd Century Group (XXII) is controlled by turnaround managers who are reforming the plant-based brand portfolio to ensure spending transparency and debt containment. Simultaneously, management is refreshing personnel and implementing a promotion strategy for low-nicotine products. Serving as the primary valuation tool, this price chart shows EV/EBITDA at 0.00. Business prospects rely on the sales success of specialized tobacco while maintaining strict FDA compliance and managing critical liquidity levels.

22nd Century Group Inc. - XXII Enterprise Value to Operating Income Before Depreciation (period 11/23/2025 - 11/12/2026)

xxiicentury.com - analytical breakdowns and key metrics (XXII)

- market price and analyst price targets:

Price Chart 22nd Century Group, Inc.|XXII - Average Forecast Price

- company stock capitalization data:

Market Value 22nd Century Group, Inc.|XXII - Total Enterprise Value

- book value of equity indicators:

Book Value per Share 22nd Century Group|XXII - Accounting Capitalization|Market Value to Book Value Ratio xxiicentury.com|XXII - Aggregate Company Assets

- debt and liquidity data:

- financial results and valuation multiples details:

XXII - Company Net Income|Expected Profit 22nd Century Group|XXII - Price to Earnings Multiple|Projected Price to Earnings 22nd Century Group, Inc.|XXII - Company Value to Earnings Growth Ratio|Enterprise Value to EBITDA Ratio 22nd Century Group, Inc.|XXII - Operating profit EBITDA|Earnings per share for the last twelve months 22nd Century Group|XXII - Earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months xxiicentury.com|XXII - Earnings per share growth rate in current year|Expected earnings per share growth for next year 22nd Century Group

Fundamental company valuation:22nd Century (XXII)

The EV/EBITDA multiple compares the total enterprise value of a business with its operating profit, neutralizing the impact of debt load and tax regimes. For 22nd Century Group (XXII), which possesses unique nicotine-free tobacco technology, the EV/EBITDA valuation trend allows for the separation of temporary financial difficulties from the actual value of assets. Analyzing this indicator helps investors distinguish market panic from the issuer's fundamentally undervalued potential.

Key competitors